Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
Immunotherapy holds great promise in cancer treatment. The challenges in advancing immunotherapies lie in patient stratification and monitoring therapy. Noninvasive detection of immune checkpoint ligand PD-L1 can serve as an important biomarker for guidance and monitoring of immunotherapy. Here in,...
| Published in: | Molecular Imaging |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-07-01
|
| Online Access: | https://doi.org/10.1177/1536012117718459 |